U.S. Stock Futures Steady as Iran Reviews U.S. Ceasefire Proposal 
Dollar Strengthens as U.S.-Iran Peace Talks Send Mixed Signals 
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
ECB Eyes Rate Hike Amid Iran Conflict-Driven Energy Price Surge 
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion 
Trump Tariffs Show Minimal Economic Impact but Boost Federal Revenue, Study Finds 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
NAB Plans to Cut 170 Jobs While Expanding Offshore Operations 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
China Opens Door to Stronger U.S. Trade Ties Amid Rising Tensions 
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025 
Oil Prices Slip as Middle East Tensions Ease, Heading for Weekly Loss 
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Barry Callebaut has halted manufacturing operations at its Weize chocolate plant in Belgium as a precautionary measure while conducting its root cause analysis and risk assessment after detecting salmonella in a production lot.
The company identified lecithin as the source of the contamination.
All chocolate products manufactured at the facility since June 25 have been placed on hold.
After the analysis, the lines will be cleaned and sanitized before production can resume.
Barry Callebaut, which informed the Belgian food authorities (FAVV) about the incident, said that their robust food safety programs allowed them to identify lecithin as the source of the contamination quickly.
The company added that they are reaching out to all customers who may have received impacted products.
The news comes after Ferrero temporarily suspended production at its Arlon facility in Belgium after the site was linked to a salmonella outbreak.
